Literature DB >> 15243828

Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Interview Survey, 2000.

Nidhi Jain1, Hussain Yusuf, Pascale M Wortley, Gary L Euler, Sabrina Walton, Shannon Stokley.   

Abstract

BACKGROUND AND OBJECTIVES: Although an effective vaccine against hepatitis B has been licensed in the United States since 1981, and successful childhood vaccination programs have been implemented, hepatitis B virus transmission continues to occur among high-risk adults. In this study, we identified factors associated with receipt of one or more doses of hepatitis B vaccine among adults at high risk for hepatitis B infection.
METHODS: We analyzed data from the 2000 National Health Interview Survey of selected adults ages 18-49 years who were at high risk for hepatitis B infection (n=1,036). Multivariable regression analysis was conducted to determine factors independently associated with vaccination.
RESULTS: Although more than 80% (n=841) of high-risk adults reported previous visits to a clinician during the past year, only 30% (n=498) of men and 31% (n=538) of women reported having received a single dose of hepatitis B vaccine. Young age (18-29 years), never being married, past blood donation, and past human immunodeficiency virus (HIV) testing were independently associated with receiving vaccination for men. For women, young age (18-29 years) and previous vaccinations were significant factors associated with vaccination receipt. Additionally, having a primary care source (men) and seeing an obstetrician-gynecologist provider in the past year (women) were significantly associated with vaccination.
CONCLUSIONS: Hepatitis B vaccination rates for high-risk adults are low, and missed opportunities are frequent. Additional strategies are needed to increase immunization rates of adults at high risk for hepatitis B.

Entities:  

Mesh:

Year:  2004        PMID: 15243828

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  16 in total

1.  Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014.

Authors:  Hope King; Jian Xing; Hazel D Dean; Deborah Holtzman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

2.  Impact of health insurance status on vaccination coverage among adult populations.

Authors:  Peng-jun Lu; Alissa O'Halloran; Walter W Williams
Journal:  Am J Prev Med       Date:  2015-04-15       Impact factor: 5.043

3.  Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007.

Authors:  F Ladak; A Gjelsvik; E Feller; S R Rosenthal; S Rosenthal; B T Montague
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

4.  Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.

Authors:  Xin Yue; Carla L Black; Alissa O'Halloran; Peng-Jun Lu; Walter W Williams; Noele P Nelson
Journal:  Vaccine       Date:  2018-02-21       Impact factor: 3.641

5.  The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.

Authors:  Deepika L Koya; Elizabeth G Hill; Paul M Darden
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

6.  Hepatitis B vaccination prevalence and its predictors among Asian, Pacific Islander, Native American, and multiracial adults in the National Health and Nutrition Examination Survey.

Authors:  John W Ayers; Hee-Soon Juon; Sunmin Lee; Eunmi Park
Journal:  J Immigr Minor Health       Date:  2010-12

7.  Economic benefits of hepatitis B vaccination at sexually transmitted disease clinics in the U.S.

Authors:  M'Kiaira K Miriti; Kaafee Billah; Cindy Weinbaum; Julie Subiadur; Richard Zimmerman; Paula Murray; Robert Gunn; Joanna Buffington
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

8.  Differences in HIV vaccine acceptability between genders.

Authors:  Lisa Kakinami; Peter A Newman; Sung-Jae Lee; Naihua Duan
Journal:  AIDS Care       Date:  2008-05

Review 9.  The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.

Authors:  Mary Jane Rotheram-Borus; Dallas Swendeman; Gary Chovnick
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

Review 10.  Understanding liver health using the National Center for Health Statistics.

Authors:  Ma Somsouk; Hal F Yee; Scott W Biggins
Journal:  Dig Dis Sci       Date:  2009-05-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.